MyFinsight
Home
Blog
About
Contact
Total property and
equipment
$1,373K
Cash and cash
equivalents
$92,310K
Marketable securities,
current
$30,817K
Prepaid expenses and
other current assets
$6,860K
Other assets
$2,999K
Operating lease
right-of-use asset
$1,421K
Property and equipment,
net
$1,256K
Less accumulated
depreciation
$117K
Total current assets
$129,987K
Total noncurrent
assets
$5,676K
Total assets
$135,663K
Accumulated deficit
-$292,231K
Total liabilities,
redeemable convertible...
$135,663K
Total stockholders'
deficit
-$264,245K
Additional paid-in capital
$27,950K
Common stock, 0.001 par
value 585,000,000 and...
$24K
Accumulated other
comprehensive income
$12K
Redeemable convertible
preferred stock-Series...
$174,494K
Redeemable convertible
preferred stock-Series...
$99,769K
Redeemable convertible
preferred stock-Series...
$49,176K
Redeemable convertible
preferred stock-Series...
$35,376K
Total liabilities
$27,687K
Redeemable convertible
preferred stock-Series...
$13,406K
Term loan
$14,808K
Total current
liabilities
$11,787K
Operating lease
liability, noncurrent
$1,092K
Accrued liabilities
$8,133K
Accounts payable
$3,147K
Operating lease liability
$507K
Back
Back
Balance Sheet
Avalyn Pharma Inc. (AVLN)
Avalyn Pharma Inc. (AVLN)
source: myfinsight.com